This would be disadvantageous as the ADC maps have also shown promising results with regard to identifying infiltrative patterns of glioma growth [32], predicting O6-methylguanine-DNA methyl-transferase (MGMT) methylation status [33] and predicting treatment outcomes and survival [33–35]. This evidence concerns the gene MGMT and central nervous system cancer.